Roger Dansey - 15 Feb 2023 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
President, R&D & CMO
Signature
By: /s/ Jennifer Prosba For: Roger D. Dansey
Issuer symbol
SGEN
Transactions as of
15 Feb 2023
Transactions value $
-$679,995
Form type
4
Filing time
17 Feb 2023, 15:23:47 UTC
Previous filing
03 Feb 2023
Next filing
22 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Options Exercise $726K +10K +10.32% $72.64 107K 15 Feb 2023 Direct F1
transaction SGEN Common Stock Sale -$27.7K -200 -0.19% $138.62 107K 15 Feb 2023 Direct F1, F2
transaction SGEN Common Stock Sale -$1.01M -7.19K -6.74% $140.55 99.5K 15 Feb 2023 Direct F1, F2, F3
transaction SGEN Common Stock Sale -$369K -2.62K -2.63% $141.04 96.9K 15 Feb 2023 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10K -20.8% $0.00 38.1K 15 Feb 2023 Common Stock 10K $72.64 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 Reflects sales of common stock executed in multiple transactions at prices ranging from $139.87 to $140.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Reflects sales of common stock executed in multiple transactions at prices ranging from $140.88 to $141.45. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5 Options vested at a rate of 25% on 8/30/2020. The remainder shall vest monthly until all the options are vested on 8/30/2023.